What are the clinical monitoring requirements for long-term dapsone use in PCP prophylaxis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18269025
Cited by: 0

Abstract

Long-term dapsone use in PCP prophylaxis necessitates frequent blood counts and liver function tests, with particular caution to screen for G6PD deficiency to prevent serious adverse effects.

Fields of Study & Subjects

Pneumocystis jirovecii pneumonia detection and treatment Pharmacogenetics and Drug Metabolism Methemoglobinemia and Tumor Lysis Syndrome

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
16 January 2026